In vitro metabolism of 3,4-methylenedioxymethamphetamine in human hepatocytes

Journal of Analytical Toxicology

Volumn 38, Issue 5, 2014, Pages 249-255

  Ramaley, Corinne ^a   Leonard, Susan C ^b   Miller, Jeffrey D ^b   Wilson, Denita Takesha Mashia ^a   Chang, Sai Y ^c   Chen, Qingyu ^a   Li, Feng ^a   Du, Chengan ^a  

^a HAMPTON UNIVERSITY   (United States)

^b MDS SCIEX   (Canada)

^c MSMS Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; GLUTATHIONE; GLUTATHIONE DERIVATIVE;

ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; LIVER CELL; LIVER METABOLISM; NEUROTOXICITY; TANDEM MASS SPECTROMETRY; CELL CULTURE; MASS SPECTROMETRY; METABOLISM;

CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTATHIONE; HEPATOCYTES; HUMANS; MASS SPECTROMETRY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE;

EID: 84899994809     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku023     Document Type: Article

References (24)

1. Capela, J.P., Carmo, H., Remiao, F., Bastos, M.L., Meisel, A., Carvalho, F. (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Molecular Neurobiology, 39, 210-271.
2. Bolla, K.I., McCann, U.D., Ricaurte, G.A. (1998) Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology, 51, 1532-1537.
3. McCann, U.D., Mertl, M., Eligulashvili, V., Ricaurte, G.A. (1999) Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology (Berl), 143, 417-425.
4. Jones, D.C., Duvauchelle, C., Ikegami, A., Olsen, C.M., Lau, S.S., de la Torre, R. et al. (2005) Serotonergic neurotoxic metabolites of ecstasy identified in rat brain. The Journal of Pharmacology and Experimental Therapeutics, 313, 422-431.
5. Erives, G.V., Lau, S.S., Monks, T.J. (2008) Accumulation of neurotoxic thioether metabolites of 3,4-(+/-)-methylenedioxymethamphetamine in rat brain. The Journal of Pharmacology and Experimental Therapeutics, 324, 284-291.
6. Ricaurte, G.A., McCann, U.D., Szabo, Z., Scheffel, U. (2000) Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). Toxicology Letters, 112-113, 143-146.
7. Schmidt, C.J., Taylor, V.L. (1988) Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. European Journal of Pharmacology, 156, 121-131.
8. Paris, J.M., Cunningham, K.A. (1992) Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Brain Research Bulletin, 28, 115-119.
9. Kreth, K., Kovar, K., Schwab, M., Zanger, U.M. (2000) Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs. Biochemical Pharmacology, 59, 1563-1571.
10. Delaforge, M., Jaouen, M., Bouille, G. (1999) Inhibitory metabolite complex formation of methylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D. Environmental Toxicology and Pharmacology, 7, 153-158.
11. Lim, H.K., Foltz, R.L. (1991) Ion trap tandem mass spectrometric evidence for the metabolism of 3,4-(methylenedioxy)methamphetamine to the potent neurotoxins 2,4,5-trihydroxymethamphetamine and 2,4,5-trihydroxyamphetamine. Chemical Research in Toxicology, 4, 626-632.
12. Hiramatsu, M., Kumagai, Y., Unger, S.E., Cho, A.K. (1990) Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. The Journal of Pharmacology and Experimental Therapeutics, 254, 521-527.
13. Lim, H.K., Zeng, S., Chei, D.M., Foltz, R.L. (1992) Comparative investigation of disposition of 3,4-(methylenedioxy)methamphetamine (MDMA) in the rat and the mouse by a capillary gas chromatographymass spectrometry assay based on perfluorotributylamine-enhanced ammonia positive ion chemical ionization. Journal of Pharmaceutical and Biomedical Analysis, 10, 657-665.
14. Maurer, H.H., Bickeboeller-Friedrich, J., Kraemer, T., Peters, F.T. (2000) Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ("Ecstasy"). Toxicology Letters, 112-113, 133-142.
15. Cho, A.K., Hiramatsu, M., Distefano, E.W., Chang, A.S., Jenden, D.J. (1990) Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis. Drug Metabolism and Disposition: the Biological Fate of Chemicals, 18, 686-691.
16. Fallon, J.K., Kicman, A.T., Henry, J.A., Milligan, P.J., Cowan, D.A., Hutt, A.J. (1999) Stereospecific analysis and enantiomeric disposition of 3,4-methylenedioxymethamphetamine (Ecstasy) in humans. Clinical Chemistry, 45, 1058-1069.
17. McCann, U.D., Ricaurte, G.A. (1991) Major metabolites of (+/-) 3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons. Brain Research, 545, 279-282.
18. McCann, U.D., Ridenour, A., Shaham, Y., Ricaurte, G.A. (1994) Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. Neuropsychopharmacology, 10, 129-138.
19. Chu, T., Kumagai, Y., DiStefano, E.W., Cho, A.K. (1996) Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochemical Pharmacology, 51, 789-796.
20. Zhao, Z.Y., Castagnoli, N., Jr, Ricaurte, G.A., Steele, T., Martello, M. (1992) Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl] propane [(methylenedioxy)methamphetamine]. Chemical Research in Toxicology, 5, 89-94.
21. Bolton, J.L., Trush, M.A., Penning, T.M., Dryhurst, G., Monks, T.J. (2000) Role of quinones in toxicology. Chemical Research in Toxicology, 13, 135-160.
22. Bai, F., Lau, S.S., Monks, T.J. (1999) Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity. Chemical Research in Toxicology, 12, 1150-1157.
23. Capela, J.P., Macedo, C., Branco, P.S., Ferreira, L.M., Lobo, A.M., Fernandes, E. et al. (2007) Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience, 146, 1743-1757.
24. Perfetti, X., O'Mathuna, B., Pizarro, N., Cuyas, E., Khymenets, O., Almeida, B. et al. (2009) Neurotoxic thioether adducts of 3,4-methylenedioxymethamphetamine identified in human urine after ecstasy ingestion. Drug Metabolism and Disposition: the Biological Fate of Chemicals, 37, 1448-1455.